Company Performance Metrics
- Roy Martin: Chief Scientific Officer and Co-Founder
- Amy Derosier: VP of Clinical AffairsPast Role: Possis Medical, Management Positions
MicroOptx is an early-stage medical device company that leverages academic bioengineering, surgical expertise, microengineering manufacturing, and nanotechnology to provide the modern solution for the vexing problem of Glaucoma. It develops a platform technology to shunt aqueous humor from the anterior chamber to the surface of the eye.
The
company is driven by a mission is to change the way the world treats glaucoma: and to halt the devastating effects of this progressive disease. MicroOptx is led by recognized medical, industry and financial veterans who are dedicated to preventing blindness.

